Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma

Patients with either Cushing's or Nelson's syndrome, both of which are associated with markedly increased levels of beta-endorphin immunoreactivity in plasma, were given tests of pain sensitivity, mood, and cognition following administration of 10 mg naloxone and saline on separate days. N...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Life sciences (1973) 1982-05, Vol.30 (21), p.1827-1833
Hauptverfasser: Mohs, Richard C., Davis, Bonnie M., Rosenberg, Gordon S., Davis, Kenneth L., Krieger, Dorothy T.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1833
container_issue 21
container_start_page 1827
container_title Life sciences (1973)
container_volume 30
creator Mohs, Richard C.
Davis, Bonnie M.
Rosenberg, Gordon S.
Davis, Kenneth L.
Krieger, Dorothy T.
description Patients with either Cushing's or Nelson's syndrome, both of which are associated with markedly increased levels of beta-endorphin immunoreactivity in plasma, were given tests of pain sensitivity, mood, and cognition following administration of 10 mg naloxone and saline on separate days. No differences were found between naloxone and saline administrations on any of these psychological measures. These results suggest that immunoreactive beta- endorphin in plasma does not exert opiate effects.
doi_str_mv 10.1016/0024-3205(82)90320-4
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_74137559</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0024320582903204</els_id><sourcerecordid>74137559</sourcerecordid><originalsourceid>FETCH-LOGICAL-c357t-570cfb1ec648c9c8ecbef0cd584243f0ede6f7a883c16b76c0d4fca6ba59c333</originalsourceid><addsrcrecordid>eNp9kFFLHDEQx4NU7Kn9BhbyVCq4Ndkku9kXoUhbBbEvvodsMvFSdpNtkjvrt2-ud_jYpxnm_5sZ-CF0QckXSmh3TUjLG9YS8Vm2lwOpXcOP0IrKfmhIx-g7tHpD3qPTnH8RQoTo2Qk66VopKG1XaPOop_gnBsA2QsYhFqydA1Pwon3AGUL2xW99eb3Cc4wWx4RNfA51GAOuxKKLh1AyfvFljdf-eY0n2MKUcXR4hKIbCDamZe33-KTzrM_RsdNThg-Heoaevn97ur1rHn7-uL_9-tAYJvrSiJ4YN1IwHZdmMBLMCI4YKyRvOXMELHSu11IyQ7ux7wyx3BndjVoMhjF2hj7tzy4p_t5ALmr22cA06QBxk1XPKeuFGCrI96BJMecETi3Jzzq9KkrUTrbamVQ7k0q26p9sxevax8P9zTiDfVs62K35zT6vOmDrIalsqiwD1qeqWNno___gL9eZkIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>74137559</pqid></control><display><type>article</type><title>Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Mohs, Richard C. ; Davis, Bonnie M. ; Rosenberg, Gordon S. ; Davis, Kenneth L. ; Krieger, Dorothy T.</creator><creatorcontrib>Mohs, Richard C. ; Davis, Bonnie M. ; Rosenberg, Gordon S. ; Davis, Kenneth L. ; Krieger, Dorothy T.</creatorcontrib><description>Patients with either Cushing's or Nelson's syndrome, both of which are associated with markedly increased levels of beta-endorphin immunoreactivity in plasma, were given tests of pain sensitivity, mood, and cognition following administration of 10 mg naloxone and saline on separate days. No differences were found between naloxone and saline administrations on any of these psychological measures. These results suggest that immunoreactive beta- endorphin in plasma does not exert opiate effects.</description><identifier>ISSN: 0024-3205</identifier><identifier>EISSN: 1879-0631</identifier><identifier>DOI: 10.1016/0024-3205(82)90320-4</identifier><identifier>PMID: 6285112</identifier><language>eng</language><publisher>Netherlands: Elsevier Inc</publisher><subject>Adult ; beta-Endorphin ; Cognition - drug effects ; Cushing Syndrome - blood ; Cushing Syndrome - psychology ; Emotions - drug effects ; Endorphins - blood ; Humans ; Middle Aged ; Naloxone - pharmacology ; Nelson Syndrome - blood ; Nelson Syndrome - psychology ; Nociceptors - drug effects</subject><ispartof>Life sciences (1973), 1982-05, Vol.30 (21), p.1827-1833</ispartof><rights>1982</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c357t-570cfb1ec648c9c8ecbef0cd584243f0ede6f7a883c16b76c0d4fca6ba59c333</citedby><cites>FETCH-LOGICAL-c357t-570cfb1ec648c9c8ecbef0cd584243f0ede6f7a883c16b76c0d4fca6ba59c333</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0024-3205(82)90320-4$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,777,781,3537,27905,27906,45976</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/6285112$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mohs, Richard C.</creatorcontrib><creatorcontrib>Davis, Bonnie M.</creatorcontrib><creatorcontrib>Rosenberg, Gordon S.</creatorcontrib><creatorcontrib>Davis, Kenneth L.</creatorcontrib><creatorcontrib>Krieger, Dorothy T.</creatorcontrib><title>Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma</title><title>Life sciences (1973)</title><addtitle>Life Sci</addtitle><description>Patients with either Cushing's or Nelson's syndrome, both of which are associated with markedly increased levels of beta-endorphin immunoreactivity in plasma, were given tests of pain sensitivity, mood, and cognition following administration of 10 mg naloxone and saline on separate days. No differences were found between naloxone and saline administrations on any of these psychological measures. These results suggest that immunoreactive beta- endorphin in plasma does not exert opiate effects.</description><subject>Adult</subject><subject>beta-Endorphin</subject><subject>Cognition - drug effects</subject><subject>Cushing Syndrome - blood</subject><subject>Cushing Syndrome - psychology</subject><subject>Emotions - drug effects</subject><subject>Endorphins - blood</subject><subject>Humans</subject><subject>Middle Aged</subject><subject>Naloxone - pharmacology</subject><subject>Nelson Syndrome - blood</subject><subject>Nelson Syndrome - psychology</subject><subject>Nociceptors - drug effects</subject><issn>0024-3205</issn><issn>1879-0631</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1982</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kFFLHDEQx4NU7Kn9BhbyVCq4Ndkku9kXoUhbBbEvvodsMvFSdpNtkjvrt2-ud_jYpxnm_5sZ-CF0QckXSmh3TUjLG9YS8Vm2lwOpXcOP0IrKfmhIx-g7tHpD3qPTnH8RQoTo2Qk66VopKG1XaPOop_gnBsA2QsYhFqydA1Pwon3AGUL2xW99eb3Cc4wWx4RNfA51GAOuxKKLh1AyfvFljdf-eY0n2MKUcXR4hKIbCDamZe33-KTzrM_RsdNThg-Heoaevn97ur1rHn7-uL_9-tAYJvrSiJ4YN1IwHZdmMBLMCI4YKyRvOXMELHSu11IyQ7ux7wyx3BndjVoMhjF2hj7tzy4p_t5ALmr22cA06QBxk1XPKeuFGCrI96BJMecETi3Jzzq9KkrUTrbamVQ7k0q26p9sxevax8P9zTiDfVs62K35zT6vOmDrIalsqiwD1qeqWNno___gL9eZkIQ</recordid><startdate>19820524</startdate><enddate>19820524</enddate><creator>Mohs, Richard C.</creator><creator>Davis, Bonnie M.</creator><creator>Rosenberg, Gordon S.</creator><creator>Davis, Kenneth L.</creator><creator>Krieger, Dorothy T.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19820524</creationdate><title>Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma</title><author>Mohs, Richard C. ; Davis, Bonnie M. ; Rosenberg, Gordon S. ; Davis, Kenneth L. ; Krieger, Dorothy T.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c357t-570cfb1ec648c9c8ecbef0cd584243f0ede6f7a883c16b76c0d4fca6ba59c333</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1982</creationdate><topic>Adult</topic><topic>beta-Endorphin</topic><topic>Cognition - drug effects</topic><topic>Cushing Syndrome - blood</topic><topic>Cushing Syndrome - psychology</topic><topic>Emotions - drug effects</topic><topic>Endorphins - blood</topic><topic>Humans</topic><topic>Middle Aged</topic><topic>Naloxone - pharmacology</topic><topic>Nelson Syndrome - blood</topic><topic>Nelson Syndrome - psychology</topic><topic>Nociceptors - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mohs, Richard C.</creatorcontrib><creatorcontrib>Davis, Bonnie M.</creatorcontrib><creatorcontrib>Rosenberg, Gordon S.</creatorcontrib><creatorcontrib>Davis, Kenneth L.</creatorcontrib><creatorcontrib>Krieger, Dorothy T.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Life sciences (1973)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mohs, Richard C.</au><au>Davis, Bonnie M.</au><au>Rosenberg, Gordon S.</au><au>Davis, Kenneth L.</au><au>Krieger, Dorothy T.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma</atitle><jtitle>Life sciences (1973)</jtitle><addtitle>Life Sci</addtitle><date>1982-05-24</date><risdate>1982</risdate><volume>30</volume><issue>21</issue><spage>1827</spage><epage>1833</epage><pages>1827-1833</pages><issn>0024-3205</issn><eissn>1879-0631</eissn><abstract>Patients with either Cushing's or Nelson's syndrome, both of which are associated with markedly increased levels of beta-endorphin immunoreactivity in plasma, were given tests of pain sensitivity, mood, and cognition following administration of 10 mg naloxone and saline on separate days. No differences were found between naloxone and saline administrations on any of these psychological measures. These results suggest that immunoreactive beta- endorphin in plasma does not exert opiate effects.</abstract><cop>Netherlands</cop><pub>Elsevier Inc</pub><pmid>6285112</pmid><doi>10.1016/0024-3205(82)90320-4</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0024-3205
ispartof Life sciences (1973), 1982-05, Vol.30 (21), p.1827-1833
issn 0024-3205
1879-0631
language eng
recordid cdi_proquest_miscellaneous_74137559
source MEDLINE; Elsevier ScienceDirect Journals
subjects Adult
beta-Endorphin
Cognition - drug effects
Cushing Syndrome - blood
Cushing Syndrome - psychology
Emotions - drug effects
Endorphins - blood
Humans
Middle Aged
Naloxone - pharmacology
Nelson Syndrome - blood
Nelson Syndrome - psychology
Nociceptors - drug effects
title Naloxone does not affect pain sensitivity, mood or cognition in patients with high levels of beta-endorphin in plasma
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T04%3A47%3A47IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Naloxone%20does%20not%20affect%20pain%20sensitivity,%20mood%20or%20cognition%20in%20patients%20with%20high%20levels%20of%20beta-endorphin%20in%20plasma&rft.jtitle=Life%20sciences%20(1973)&rft.au=Mohs,%20Richard%20C.&rft.date=1982-05-24&rft.volume=30&rft.issue=21&rft.spage=1827&rft.epage=1833&rft.pages=1827-1833&rft.issn=0024-3205&rft.eissn=1879-0631&rft_id=info:doi/10.1016/0024-3205(82)90320-4&rft_dat=%3Cproquest_cross%3E74137559%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=74137559&rft_id=info:pmid/6285112&rft_els_id=0024320582903204&rfr_iscdi=true